436 related articles for article (PubMed ID: 2858911)
1. [Recommendations for secondary prevention of the clinical coronary cardiopathy].
Rev Esp Cardiol; 1985; 38(1):14-20. PubMed ID: 2858911
[TBL] [Abstract][Full Text] [Related]
2. [Cardiovascular risk factors and prevention in women: similarities and differences].
Sclavo M
Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
[TBL] [Abstract][Full Text] [Related]
3. [Women and ischemic cardiopathy].
Assmann G; Davignon J; Fernández Cruz A; Gotto AM; Jacotot B; Lewis B; Paoletti R
Rev Clin Esp; 1989 Oct; 185(6):308-15. PubMed ID: 2695994
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
5. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
6. Classical risk factors and emerging elements in the risk profile for coronary artery disease.
Gensini GF; Comeglio M; Colella A
Eur Heart J; 1998 Feb; 19 Suppl A():A53-61. PubMed ID: 9519344
[TBL] [Abstract][Full Text] [Related]
7. Joint recommendations on secondary prevention for persons with clinical coronary heart disease. International Society and Federation of Cardiology.
Bol Asoc Med P R; 1985 Apr; 77(4):151-6. PubMed ID: 3859298
[No Abstract] [Full Text] [Related]
8. Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
Campbell NR; Burgess E; Choi BC; Taylor G; Wilson E; Cléroux J; Fodor JG; Leiter LA; Spence D
CMAJ; 1999 May; 160(9 Suppl):S1-6. PubMed ID: 10333847
[TBL] [Abstract][Full Text] [Related]
9. Atherosclerotic risk factors in cardiovascular disease.
LaRosa JC
J Reprod Med; 1986 Sep; 31(9 Suppl):906-12. PubMed ID: 3772910
[TBL] [Abstract][Full Text] [Related]
10. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
[TBL] [Abstract][Full Text] [Related]
11. European and American recommendations for coronary heart disease prevention.
Wood D
Eur Heart J; 1998 Feb; 19 Suppl A():A12-9. PubMed ID: 9519337
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk factors and lipoprotein profile in French Canadians with premature CAD: impact of the National Cholesterol Education Program II.
McNicoll S; Latour Y; Rondeau C; Bouthillier D; Davignon J; Genest J
Can J Cardiol; 1995 Feb; 11(2):109-16. PubMed ID: 7866933
[TBL] [Abstract][Full Text] [Related]
13. Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society.
Eur Heart J; 1987 Jan; 8(1):77-88. PubMed ID: 3816842
[TBL] [Abstract][Full Text] [Related]
14. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
15. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
[TBL] [Abstract][Full Text] [Related]
16. [Modifying increased plasma cholesterol levels in secondary prevention of coronary heart disease].
Jost S; Lichtlen PR
Z Kardiol; 1995 Aug; 84(8):577-95. PubMed ID: 7571764
[TBL] [Abstract][Full Text] [Related]
17. Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials.
Yusuf S; Lessem J; Jha P; Lonn E
J Hypertens Suppl; 1993 Jun; 11(4):S61-73. PubMed ID: 8104243
[TBL] [Abstract][Full Text] [Related]
18. Lifestyle modifications to prevent and control hypertension. 4. Recommendations on physical exercise training. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
Cléroux J; Feldman RD; Petrella RJ
CMAJ; 1999 May; 160(9 Suppl):S21-8. PubMed ID: 10333850
[TBL] [Abstract][Full Text] [Related]
19. Management of vascular risk factors in the hypertensive patient.
Taylor SH
J Hum Hypertens; 1990 Oct; 4 Suppl 3():10-6. PubMed ID: 2148191
[TBL] [Abstract][Full Text] [Related]
20. [The best of epidemiology and cardiovascular prevention in 2006].
Thomas D; Collet JP; Cottin Y; Cournot M; Ducimetière P; Ferrières J; Paillard F; Valensi P; Zeller M; Cambou JP
Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():57-64. PubMed ID: 17405566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
